Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TXMD holding history

TherapeuticsMD, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings

Shares (Q2 2026)
246
Value
$544
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TXMD by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026246$544<0.1%00.0%UnchangedHolders
Q1 2026246$497<0.1%00.0%UnchangedHolders
Q4 2025246$401<0.1%00.0%UnchangedHolders
Q3 2025246$264<0.1%00.0%UnchangedHolders
Q2 2025246$285<0.1%00.0%UnchangedHolders
Q1 2025246$228<0.1%00.0%UnchangedHolders
Q4 2024246$212<0.1%00.0%UnchangedHolders
Q3 2024246$408<0.1%00.0%UnchangedHolders
Q2 2024246$396<0.1%−164−40.0%ReducedHolders
Q1 2024410$939<0.1%+164+66.7%AddedHolders
Q4 2023246$554<0.1%00.0%UnchangedHolders
Q3 2023246$743<0.1%00.0%UnchangedHolders
Q2 2023246$1.01K<0.1%00.0%UnchangedHolders
Q1 2023246$923<0.1%00.0%UnchangedHolders
Q4 2022246$1.38K<0.1%00.0%UnchangedHolders
Q3 2022246$2.00K<0.1%00.0%UnchangedHolders
Q2 2022246$2.00K<0.1%00.0%UnchangedConverted for a 1-for-50 splitHolders
Q1 202212,300$5.00K<0.1%00.0%UnchangedHolders
Q4 202112,300$4.00K<0.1%−7,976−39.3%ReducedHolders
Q3 202120,276$15.0K<0.1%−242−1.2%ReducedHolders
Q2 202120,518$25.0K<0.1%+242+1.2%AddedHolders
Q1 202120,276$27.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.